Imperial has been awarded a 5-year Wellcome Trust Clinical PhD programme, making it one of only seven schemes to have successfully obtained funding.
The Imperial Immunity, Inflammation, Infection and Informatics (4i) Clinician Scientist Programme lead by Professors Gavin Screaton and Matthew Pickering will award four fellowships per year over a period of five years.
Professor Gavin Screaton said, "our aim is to develop the clinical academic leaders of the future."
"The clinician scientist, through education and training in both biomedical science and clinical medicine, is uniquely positioned to develop key insights and identify knowledge gaps between biomedical research and clinical practice. The Imperial Clinician Scientist programme focuses on the academic strengths of the College that are relevant to major health problems: Immunity, Inflammation, Infection and Informatics."
Professor Matthew Pickering said, "The Imperial Immunity, Inflammation, Infection and Informatics (4i) programme will offer an unparalleled and comprehensive portfolio of high quality internationally competitive research fellowships."
"We have shaped our scheme to enable ‘early career success’ by placing talented individuals in a highly supportive environment, and providing each individual with cutting-edge research projects under experienced supervision and mentorship."
The scheme will be supported by the Imperial Clinical Academic Training Office and the NIHR Imperial Biomedical Research Centre which will provide funding for additional fellowships. The first cohort will be recruited this winter, to start in autumn 2017
Article text (excluding photos or graphics) available under an Attribution-NonCommercial-ShareAlike Creative Commons license.
Photos and graphics subject to third party copyright used with permission or © Imperial College London.